News List

Advancells achieves positive outcome of stem cell therapy for Multiple Sclerosis


Advancells has announced the successful reversal of Multiple Sclerosis using Adult Stem Cells and Regenerative medicine in the first clinical trial.
By Team ABLE

Advancells, an India-based research oriented company, has announced the successful reversal of Multiple Sclerosis using Adult Stem Cells and Regenerative medicine in the pilot patient of a planned clinical trial.

According to a press release by Advancells, Auckland, New Zealand resident Rahul Gupta has become the first patient to be recruited under a pilot study to ascertain the efficacy of Autologous Adult Stem Cells in reversing Multiple Sclerosis (MS).

MS is a disease of the nerves where the insulating covers of the nerve cells in the brain and nerves are damaged, thus effecting the communication between those nerves and the brain. This results in disabling the patient in their muscle movement, vision, coordination and sensation.

The release further explained that Rahul Gupta was first diagnosed with MS in 2010 and has had multiple relapses of the disease in the past 7 years. His symptoms had been progressing at a fast pace and he had almost lost his power to walk. This is when he approached India-based Advancells, who have been working in the field of regenerative medicine and research on stem cells for therapeutic usages. The patient was accepted as a trial patient for Advancells unique Adult Stem Cell therapy program and the procedure was carried out in New Delhi in June 2017.

To perform the therapy, bone marrow of the patient was aspirated and adult stem cells were separated from them. These unmanipulated cells were then reinjected back in the patient at specific points and the patient was put under physiotherapy and dietary routine.